These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16792935)

  • 1. [Antibiotic treatment for legionellosis].
    Calbo E; Garau J
    Enferm Infecc Microbiol Clin; 2006; 24(6):357-9. PubMed ID: 16792935
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila.
    Nakamura S; Yanagihara K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Senjyu H; Saito A; Kohno S
    J Infect; 2009 Sep; 59(3):222-4. PubMed ID: 19592113
    [No Abstract]   [Full Text] [Related]  

  • 3. Prescription of macrolides in community-acquired pneumonia: science or art?
    Rello J
    Chest; 1998 May; 113(5):1155-8. PubMed ID: 9596285
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment for Legionnaires' disease. Macrolides or quinolones?].
    Falcó V; Molina I; Juste C; Crespo M; Almirante B; Pigrau C; Ferrer A; Bravo C; Palomar M; Pahissa A
    Enferm Infecc Microbiol Clin; 2006; 24(6):360-4. PubMed ID: 16792936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New macrolides or new quinolones as monotherapy for patients with community-acquired pneumonia: our cup runneth over?
    Yu VL; Vergis EN
    Chest; 1998 May; 113(5):1158-9. PubMed ID: 9596286
    [No Abstract]   [Full Text] [Related]  

  • 6. Legionellosis.
    Pedro-Botet ML; Sabrià M
    Semin Respir Crit Care Med; 2005 Dec; 26(6):625-34. PubMed ID: 16388431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legionnaires' disease and pneumonia. Beware the temptation to underestimate this "exotic" cause of infection.
    Akbas E; Yu VL
    Postgrad Med; 2001 May; 109(5):135-8, 141-2, 147. PubMed ID: 11381664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empirical Therapy of Community-Acquired Pneumonia: Advancing Evidence or Just More Doubt?
    Mandell LA; Waterer GW
    JAMA; 2015 Jul; 314(4):396-7. PubMed ID: 26219057
    [No Abstract]   [Full Text] [Related]  

  • 9. The debate on antibiotic therapy for patients hospitalized for pneumonia: where should we go from here?
    Lee JS; Fine MJ
    JAMA Intern Med; 2014 Dec; 174(12):1901-3. PubMed ID: 25285980
    [No Abstract]   [Full Text] [Related]  

  • 10. Empiric treatment of ambulatory community-acquired pneumonia: always include treatment for atypical agents.
    Marrie TJ
    Infect Dis Clin North Am; 2004 Dec; 18(4):829-41. PubMed ID: 15555827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complicated nosocomial pneumonia due to Legionella pneumophila in an immunocompromised child.
    Trübel HK; Meyer HG; Jahn B; Knuf M; Kamin W; Huth RG
    Scand J Infect Dis; 2002; 34(3):219-21. PubMed ID: 12030402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative analysis of guidelines for the treatment of community-acquired pneumonias].
    Rodríguez de Castro F
    Arch Bronconeumol; 1999 Jun; 35(6):253-6. PubMed ID: 10410203
    [No Abstract]   [Full Text] [Related]  

  • 13. Legionnaires disease and the updated IDSA guidelines for community-acquired pneumonia.
    Yu VL; Ramirez J; Roig J; Sabria M
    Clin Infect Dis; 2004 Dec; 39(11):1734-7; author reply 1737-8. PubMed ID: 15578385
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe community-acquired pneumonia due to Legionella pneumophila Serogroup 6.
    Chen CY; Chen KY; Hsueh PR; Yang PC
    J Formos Med Assoc; 2006 Mar; 105(3):256-62. PubMed ID: 16520845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
    Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS
    Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial strategy for severe community-acquired legionnaires' disease: a multicentre retrospective observational study.
    Cecchini J; Tuffet S; Sonneville R; Fartoukh M; Mayaux J; Roux D; Kouatchet A; Boissier F; Tchir M; Thyrault M; Maury E; Jochmans S; Mekontso Dessap A; Brun-Buisson C; de Prost N
    J Antimicrob Chemother; 2017 May; 72(5):1502-1509. PubMed ID: 28204479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophila.
    Tan JS; File TM; DiPersio JR; DiPersio LP; Hamor R; Saravolatz LD; Stout JE
    Clin Infect Dis; 2001 Jun; 32(11):1562-6. PubMed ID: 11340527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of non-nosocomial pneumonia].
    Drömann D; Schaaf B
    MMW Fortschr Med; 2008 Jan; 150(3-4):31-4; quiz 35. PubMed ID: 18326476
    [No Abstract]   [Full Text] [Related]  

  • 19. Monotherapy or combination therapy for hospitalized patients with community-acquired pneumonia: not yet the end of the story?
    Laterre PF
    Clin Infect Dis; 2008 May; 46(10):1510-2. PubMed ID: 18419483
    [No Abstract]   [Full Text] [Related]  

  • 20. Importance of atypical pathogens of community-acquired pneumonia.
    Plouffe JF
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S35-9. PubMed ID: 10984326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.